DVA Davita Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 70
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 72
Relative Profitability: Rel. Profitability: 39

EPS in 2026 (TTM): $10.93

Last Report Period Date: Mar 31, 2026

Based on the company's latest reports for March 2026, the current 12-month EPS is $10.93. Davita's earnings per share in 2025 was reported at $10.06, marking a decline from $11.02 in 2024. In the quarterly report ending on Mar 31, 2026, DVA's earnings per share amounted to $2.93.

DVA earnings history

Historical annual and quarterly earnings per share (EPS) data for Davita
EPS (TTM)
$10.93
EPS Growth YoY (Quarterly)
42.9%
EPS (Quarterly)
$2.93
EPS Growth (Quarterly)
-10.9%

Davita had an yealy earnings per share of $10.06, showing a decline of 8.7% from $11.02 recorded in 2024. The quarterly earnings per share for the period ending Mar 31, 2026, was $2.93, showing a 42.9% increase compared to the same quarter last year. The trailing twelve months EPS for DVA is $10.93 as of March 2026. Davita's full-year EPS for 2024 was $11.02, a 44.6% rise compared to the previous year.

DVA earnings chart

DVA EPS growth history

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
42.9%
EPS growth YoY
-8.7%
EPS growth 3Y avg
18.6%
EPS growth 5Y avg
9.3%

In the past 12 months, Davita has recorded an earnings per share growth rate of 42.9% (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 18.6% per year. In the last five years, the company had an average annual EPS growth of 9.3%. When assessed over a ten-year period, DVA's average EPS annual growth was 23%.

DVA Earnings Waterfall

Breakdown of revenue, profit and net income for Davita

DVA Earnings vs Peers

What are the earnings of DVA compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
UHS Universal Health Services Inc 6.01 36.5% 36.4% 16.2%
THC Tenet Healthcare Corp 9.33 -52.7% 59.6% 32.7%
MD Mednax Inc 11.42 265.5% 35.6% N/A
DVA Davita Inc 19.3 -8.7% 18.6% 9.3%
LH Laboratory Corp Of America Holdings 22.76 18.6% -9.1% -8%

All data is based on quarterly TTM periods, unless otherwise specified.